A Study of IDN-6556 in Subjects With Liver Cirrhosis

NCT02230670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cirrhosis
Hepatic Cirrhosis

Interventions

DRUG: IDN-6556
DRUG: Placebo

Sponsor

Conatus Pharmaceuticals Inc.